Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Clinical trials have demonstrated that exendin-4-based therapies reduce HbA1c levels by approximately 9-16 mmol/mol (0.81.5%) when added to existing oral antidiabetic agents
These insights underscore the significance of GLP-1 receptor agonists in weight management strategies
They also support our day-to-day strength and mobility, which becomes more important as we age
Resume your next dose as directed by your provider
Semaglutide Semaglutide is a GLP-1 receptor agonist, which means it mimics a naturally occurring hormone responsible for regulating blood sugar and appetite
US$ 27.96
US$ 27.95
US$ 23.04
